Kay NE - Search Results

1

Interleukin 4 content in chronic lymphocytic leukaemia (CLL) B cells and blood CD8+ T cells from B-CLL patients: impact on clonal B-cell apoptosis.

Kay NE, Han L, Bone N, Williams G. Kay NE, et al. Br J Haematol. 2001 Mar;112(3):760-7. doi: 10.1046/j.1365-2141.2001.02605.x. Br J Haematol. 2001. PMID: 11260081 Free article.

2

Expansion of a lymphocyte population co-expressing T4 (CD4) and T8 (CD8) antigens in the peripheral blood of a normal adult male.

Kay NE, Bone N, Hupke M, Dalmasso AP. Kay NE, et al. Blood. 1990 May 15;75(10):2024-9. Blood. 1990. PMID: 2140062 Free article.

3

Defective expression of T cell antigens in chronic lymphocytic leukaemia: relationship to T cell dysfunction.

Kay NE, Kaplan ME. Kay NE, et al. Br J Haematol. 1984 May;57(1):105-11. doi: 10.1111/j.1365-2141.1984.tb02870.x. Br J Haematol. 1984. PMID: 6609711

4

Human T-cell function in experimental ascorbic acid deficiency and spontaneous scurvy.

Kay NE, Holloway DE, Hutton SW, Bone ND, Duane WC. Kay NE, et al. Am J Clin Nutr. 1982 Jul;36(1):127-30. doi: 10.1093/ajcn/36.1.127. Am J Clin Nutr. 1982. PMID: 6979920

5

Circulating CD19+ blood cell levels in myeloma. ECOG Myeloma Clinical Trials Laboratory Study Group.

Kay NE, Oken MM, Bone N, Kyle RA, Greipp P, Van Ness B, Leong T. Kay NE, et al. Blood. 1995 Nov 15;86(10):4000-1. Blood. 1995. PMID: 7579374 Free article. No abstract available.

6

Confirmation of Rb gene defects in B-CLL clones and evidence for variable predominance of the Rb defective cells within the CLL clone.

Kay NE, Suen R, Ranheim E, Peterson LC. Kay NE, et al. Br J Haematol. 1993 Jun;84(2):257-64. doi: 10.1111/j.1365-2141.1993.tb03061.x. Br J Haematol. 1993. PMID: 8398827

7

Analysis of blood T-cell cytokine expression in B-chronic lymphocytic leukaemia: evidence for increased levels of cytoplasmic IL-4 in resting and activated CD8 T cells.

Mu X, Kay NE, Gosland MP, Jennings CD. Mu X, et al. Among authors: kay ne. Br J Haematol. 1997 Mar;96(4):733-5. doi: 10.1046/j.1365-2141.1997.d01-2107.x. Br J Haematol. 1997. PMID: 9074413 Free article.

8

Circulating blood B cells in multiple myeloma: analysis and relationship to circulating clonal cells and clinical parameters in a cohort of patients entered on the Eastern Cooperative Oncology Group phase III E9486 clinical trial.

Kay NE, Leong T, Kyle RA, Greipp P, Billadeau D, Van Ness B, Bone N, Oken MM. Kay NE, et al. Blood. 1997 Jul 1;90(1):340-5. Blood. 1997. PMID: 9207470 Free article. Clinical Trial.

9

T-helper phenotypes in the blood of myeloma patients on ECOG phase III trials E9486/E3A93.

Kay NE, Leong T, Bone N, Kyle RA, Greipp PR, Van Ness B, Oken MM. Kay NE, et al. Br J Haematol. 1998 Mar;100(3):459-63. doi: 10.1046/j.1365-2141.1998.00609.x. Br J Haematol. 1998. PMID: 9504626 Free article. Clinical Trial.

10

Altered T cell repertoire usage in CD4 and CD8 subsets of multiple myeloma patients, a Study of the Eastern Cooperative Oncology Group (E9487).

Kay N, Leong T, Kyle RA, Greipp P, Van Ness B, Bone N, Oken MM. Kay N, et al. Leuk Lymphoma. 1999 Mar;33(1-2):127-33. doi: 10.3109/10428199909093733. Leuk Lymphoma. 1999. PMID: 10194129 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

473 results

Search Page

Filters